Skip to main content
All lobbying filings

BLUEBIRD STRATEGIES

Lobbying for CELLTRION USA, INC. · Biopharmaceutical Company

 Filing 4th Quarter - Report
4th Quarter (Oct 1 - Dec 31) 2025 · New Jersey · House · Senate · posted Jan 21, 2026

Official filing document

 Lobbying activity 1
Health Issues

Issues related to drug pricing, FDA drug regulations

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem